Active, not recruitingNCT05378386

ALTERRA Post-Approval Study

Studying Tetralogy of Fallot

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Edwards Lifesciences
Intervention
Edwards Alterra Adaptive Prestent with SAPIEN 3 Transcatheter Pulmonary Valve System(device)
Enrollment
150 enrolled
Eligibility
All sexes
Timeline
20222035

Study locations (24)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05378386 on ClinicalTrials.gov

Other trials for Tetralogy of Fallot

Additional recruiting or active studies for the same condition.

See all trials for Tetralogy of Fallot

← Back to all trials